Filing Date |
T Date |
Ticker |
Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
#f |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
8/22/25 16:07 | 8/21/25 | LYEL | Health | Drug | Pharmaceutical Preparations | Seely Lynn | CA | DO | P,CEO | 2 | S.m | -85 | 10.53 | 0 | -8 | 68 | D | |||||||||||||||
8/22/25 16:06 | 8/21/25 | LYEL | Health | Drug | Pharmaceutical Preparations | Hill Stephen J. | CA | O | COO | 2 | S.m | -13 | 10.53 | 0 | -1 | 16 | D | |||||||||||||||
8/22/25 16:03 | 8/21/25 | LYEL | Health | Drug | Pharmaceutical Preparations | Newton Charles W. | CA | O | CFO | 2 | S.m | -18 | 10.53 | 0 | -2 | 25 | D | |||||||||||||||
8/22/25 16:02 | 8/21/25 | LYEL | Health | Drug | Pharmaceutical Preparations | Lee Gary K. | CA | O | Chief Sc | 2 | S.m | -18 | 10.53 | 0 | -2 | 16 | D |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |